本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Compugen医疗

1.44
-0.0400-2.70%
成交量:7.53万
成交额:10.86万
市值:1.35亿
市盈率:-9.00
高:1.47
开:1.44
低:1.42
收:1.48
数据加载中...
2025/03/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/23

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/08/23

SEC问询函

Form CORRESP - Correspondence
2023/06/23

SEC问询函

Form CORRESP - Correspondence
2023/04/14

SEC问询函

Form CORRESP - Correspondence
2023/02/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/28

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals